Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
VistaGen Announces Closing of $15,000,000 Underwritten Offering of Common Stock and Warrants to Purchase Common Stock
-
GigCapital, Inc. Announces Closing of Public Offering of Common Stock
-
Spark Therapeutics (ONCE) PT Lowered to $60 at Chardan Capital Markets
-
VistaGen Therapeutics (VTGN) Prices 10M Offering of Common Stock and Warrants
-
VistaGen Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock
-
GigCapital Inc. (GIG.U) Prices 12.5M Share IPO at $10/Sh
-
GigCapital, Inc. Announces Pricing of $125,000,000 Initial Public Offering
-
Tabula Rasa HealthCare Announces Pricing of Sale of Shares of Common Stock
-
Esperion Therapeutics (ESPR) PT Raised to $75 at Chardan Capital Markets; Positive Bias
-
Tabula Rasa HealthCare (TRHC) Announces 3M Share Offering
-
Tabula Rasa HealthCare Announces Proposed Offering of Common Stock
-
Chardan Capital Markets Downgrades Ituran Location & Control (ITRN) to Neutral
-
Alnylam Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Alnylam Pharma (ALNY) Prices 5.6M Share Common Offering at $125/Sh
-
Alnylam Pharmaceuticals Prices Public Offering of Common Stock
-
Vuzix Corp. (VUZI): Entering 2018 with Significant Momentum - Chardan
-
Chardan Capital Markets Upgrades Sage Therapeutics (SAGE) to Buy
-
Jensyn Acquisition Corp (JSYN) to Merge with BAE Energy Management
-
Jensyn Acquisition Corp. Announces Agreement for Business Combination with BAE Energy Management, LLC
-
Regenxbio Inc. (RGNX) PT Raised to $85 at Chardan Capital Markets
-
CaesarStone Sdot-Yam (CSTE) PT Lowered to $32 at Chardan Capital Markets
-
Vascular Biogenics Ltd (VBLT) PT Raised to $25 at Chardan Capital Markets
-
Chardan Capital Markets Downgrades NICE Systems Ltd (NICE) to Neutral Citing Valuation
-
Benefitfocus (BNFT) PT Lowered to $28 at Chardan Capital Markets on 3Q Report; 'Management Sounded Cautious About Outlook for Topline in 2018'
-
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million
-
uniQure Announces Closing of its Public Offering
-
Social Reality (SRAX) Reports $5.18M Private Placement with Existing Shareholders
-
SRAX Announces Private Placement of $5.18 Million with Existing Shareholders
-
uniQure (QURE) Prices 5M Share Common Offering at $18.25/Sh
-
uniQure Announces Pricing of its Public Offering
-
uniQure (QURE) to Offer 5M Shares
-
uniQure Announces Proposed Public Offering
-
Pre-Open Stock Movers 10/20: (SKX) (TEAM) (QURE) Higher; (DRRX) (NCR) (CELG) (GE) Lower (more...)
-
After-Hours Stock Movers 10/19: (SKX) (TEAM) (IMPV) (PYPL) Higher; (NCR) (CELG) (ATHN) Lower (more...)
-
uniQure BV (QURE) PT Raised 180% to $35 at Chardan Capital Markets; Sees Heb B Leadership in GT
-
Asterias Biotherapeutics Announces Closing of $10.4 Million Registered Direct Offering
-
Black Ridge Acquisition Corp. Announces Closing Of Over-Allotment Option With Respect To Initial Public Offering
-
Black Ridge Oil & Gas, Inc. Announces Closing of SPAC Over-allotment Related to Initial Public Offering
-
FBR Capital Markets & Co.’s Senior Equity Research Healthcare Analyst Madhu Kumar, Ph.D. Named to Institutional Investor’s 2017 All-America Research Team Rising Stars List
-
BioTime, Inc. Announces Closing of Public Offering and Underwriters’ Full Exercise of Over-Allotment Option
-
Social Reality (SRAX) to Explore Strategic Alternatives for SRAXmd Healthcare Business
-
Social Reality, Inc. to Pursue Strategic Alternatives for SRAXmd Healthcare Business
-
Pre-Open Stock Movers 10/16: (TRXC) (RT) (EXEL) Higher; (AMPE) (ADBE) (ISRG) Lower (more...)
-
Asterias Biotherapeutics Announces $10.4 Million Registered Direct Offering
-
NICE Systems Ltd (NICE) PT Raised to $91 at Chardan Capital Markets
-
22nd Century Group (XXII) PT Raised to $11.50 at Chardan Capital Markets; a Solution to Big Tobacco's $30B Problem
-
BioTime (BTX) Prices 9.6M Share Common Offering at $2.60/Sh
-
BioTime, Inc. Announces Pricing of $25.0 Million Public Offering of Common Stock
-
Globalstar (GSAT) Equity Raise Positions it to Focus on Spectrum Monetization - Chardan Capital Markets
-
Globalstar Announces Completion of Public Offering of Voting Common Stock

